{
    "nctId": "NCT03017560",
    "briefTitle": "Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer",
    "officialTitle": "Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Treatment, Cognitive Deficits",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Verbal Memory",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women ages 65-90\n* Chemotherapy treatment for early-stage (I, IIa, IIb, IIIa) breast cancer\n* Post-menopausal\n* High school education or greater\n* Geographically available for followup assessment\n* Native English speaker\n* Normal or corrected to near-normal hearing and vision\n\nExclusion Criteria:\n\n* Psychiatric history including past or current psychotic spectrum disorders (schizophrenia, bipolar disorder, major depressive disorder, dementia, schizoaffective disorder)\n* Brain injury (e.g., stroke, heart attack, aneurysm, tumor, concussion, head trauma)\n* Brain disease\n* History of brain irradiation or surgery\n* Current or past disease/disorder of the central nervous system or medical condition affecting cognitive functioning (e.g., chronic migraine, epilepsy or history of seizures, encephalitis, meningitis, multiple sclerosis, thyroid condition, Parkinson's, Alzheimer's, Huntington's disease)\n* Active diagnosis of autoimmune or inflammatory disorder (e.g., systemic lupus erythematosus, rheumatoid arthritis, vasculitis, insulin-dependent diabetes, Crohn's disease, uncontrolled allergic reaction or asthma)\n* History of other cancer, except for basal cell carcinoma\n* Development of a second primary malignancy during the study\n* Drug or alcohol abuse (i.e., more than 7 drinks per week)\n* Chronic use of oral steroid medication\n* Former (prior to early-stage breast cancer) intrathecal therapy, radiation therapy, chemotherapy, or any neoadjuvant chemotherapy\n* Acquired or developmental speech, language, or learning disorders (e.g., aphasia, dyslexia, dysgraphia, auditory processing disorder, autism, developmental delay)\n* Hormone replacement therapy, excluding vaginal estrogen",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}